Conagra (NYSE: CAG) is a large food maker that has to deal with the everyday ups and downs in consumer buying habits. It is doing that today, noting that there are some unique lingering effects from the coronavirus pandemic. However, the really important goal for 2024 is likely t
The discount being offered for Target (NYSE: TGT) shares in 2023 might be getting out of hand. The retailer's stock is down 25% so far this year compared to a 14% increase for the S&P 500. That slump comes even as retailing peers like Walmart (NYSE: WMT) and Costco Wholesale
(RTTNews) - Syngenta Group reported that its Group sales for the first nine months of 2023 were $24.3 billion, down 6 percent year-on-year, or a decline of 3% CER. EBITDA was 22% lower or down 20% CER to $3.5 billion. Syngenta Group's EBITDA margin for the first nine months was 1
Leggett & Platt (NYSE: LEG) is not a good stock for conservative investors. In fact, the manufacturer of a diverse group of products has seen its share prices fall nearly 60% from their 2021 highs. That's painful, but perhaps it's understandable given the company's cyclical b
Many income-focused investors put too much emphasis on a stock's current yield. A better approach is to focus on a company's ability to increase its payout.
The financial markets are grinding through a lot of headwinds right now, with rising interest rates and persistent inflation creating obstacles for the economy. But the good news is that uncertainty compresses valuations for top stocks and gives long-term investors the opportunit
Etsy (NASDAQ: ETSY), an e-commerce marketplace for craftspeople and vintage goods, has fallen to its lowest level since the beginning of the pandemic in 2020. Financial results were lackluster in the third quarter of 2023, and despite e-commerce sales heating up elsewhere (like t
Vertex Pharmaceuticals (NASDAQ: VRTX) generates billions of dollars in annual revenues from its treatments for the rare disease cystic fibrosis. And Vertex should continue to dominate in cystic fibrosis and bring in blockbuster revenue well into the future thanks to its life-savi
The cannabis industry in Canada is in shambles. Pick a random pot stock and you're sure to find an investment that is down big over the past few years. Canopy Growth (NASDAQ: CGC) and Tilray Brands (NASDAQ: TLRY) are no exception -- they've fallen more than 50% in just the past 1
December S&P 500 futures (ESZ23) are up +0.12%, and December Nasdaq 100 E-Mini futures (NQZ23) are up +0.01% this morning as market participants once again looked ahead to remarks from U.S. Federal Reserve Chief Jerome Powell for more clues on interest rates.
(RTTNews) - Indian shares fell modestly on Thursday, with hawkish comments from Federal Reserve officials and a rebound in oil prices denting sentiment.
The Indian rupee traded in a narrow band and closed little-changed on Thursday as likely intervention from the Reserve Bank of India limited losses in the currency.
Activist investors generally get involved with a company because they want management or the board to do something. And that's exactly what you need to understand when you see an activist investor taking a big stake in a stock you own. What happened at Beyond, Inc. (NYSE: BYON),
(RTTNews) - Eli Lilly and Co. (LLY) said that the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for Chronic Weight Management, a new option for the treatment of Obesity or Overweight with weight-related medical problems.
An "electrical incident" last month has curtailed the output of liquefied natural gas (LNG) at Chevron's Gorgon facility in Western Australia, a company spokesperson said on Thursday.
(RTTNews) - Takeda (TAK) said that the U.S. Food and Drug Administration has approved Fruzaqla (fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer or mCRC who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based